*Spinal Muscular Atrophy affects one in 6,000 children; no known cure*
COLUMBIA, Mo. – A team of University of Missouri researchers have found that targeting a synthetic molecule to a specific gene could help the severity of the disease Spinal Muscular Atrophy (SMA) – the leading genetic cause of infantile death in the world. (more…)
Experienced meditators seem to be able switch off areas of the brain associated with daydreaming as well as psychiatric disorders such as autism and schizophrenia, according to a new brain imaging study by Yale researchers.
Meditation’s ability to help people stay focused on the moment has been associated with increased happiness levels, said Judson A. Brewer, assistant professor of psychiatry and lead author of the study published the week of Nov. 21 in the Proceedings of the National Academy of Sciences. Understanding how meditation works will aid investigation into a host of diseases, he said. (more…)
EAST LANSING, Mich. — An inexpensive drug that treats Type-2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study by a Michigan State University researcher. (more…)
Yale School of Medicine researchers have discovered that a variant of a gene linked to heart disease also increases the risk of deadly aneurysms of blood vessels in the brain. The discovery of this link raises hopes for new treatments for intracranial aneurysms, which affect more than a half million people worldwide annually.
“Existing drugs already target this common pathway and, in the future, could help treat or prevent aneurysms in people who are at risk,” said Murat Gunel, professor of neurosurgery, genetics and neurobiology and senior author of the study, published the week of Nov. 21 in the Proceedings of the National Academy of Sciences. (more…)
Distinct neural pathways are important for different aspects of language processing, researchers have discovered, studying patients with language impairments caused by neurodegenerative diseases. (more…)
Researchers at Yale University have discovered new chemical compounds that prevent HIV from replicating in human T-cells. These compounds could result in new, highly effective HIV treatments that are 10 to 2000 times more potent than HIV drugs now on the market.
“The current compounds or slight variants could become drugs,” said Professor William L. Jorgensen, one of two principal investigators behind the research. The other is Karen S. Anderson, a pharmacology professor at Yale School of Medicine. They reported their results online Nov. 15 in the Journal of Medicinal Chemistry. (more…)
COLUMBIA, Mo. – More than 20 years ago, Charles Borduin, a University of Missouri researcher, developed a treatment for juvenile offenders that has become one of the most widely used evidence-based treatments in the world. Now, he has found that the treatment continues to have positive effects on former participants more than 20 years after treatment. (more…)
*Research into aphasia – the inability to speak or write well-formulated sentences and words – is strong at the UA. Researchers have received $2 million toward the study of the condition.*
The National Institutes of Health have awarded the University of Arizona’s Aphasia Research Project in the department of speech, language and hearing sciences a $2 million grant to research communication impairments in adults who have suffered brain injury.
Aphasia – the inability to speak or write well-formulated sentences and words – is a common result of a stroke or a traumatic brain injury such as the one suffered by Rep. Gabrielle Giffords, who was shot in the head earlier this year. The bullet damaged regions of the brain that are critical for language and control of the right side of the body. (more…)
